The NASA Scientist Who Changed Cancer Diagnostics Forever

Dr. Arnon Chait, CEO of Cleveland Diagnostics, discusses his transition from NASA to the healthcare innovation space and the development of cancer diagnostics.

Dr. Chait emphasizes the importance of using diagnostic advancements to strike a balance between over-screening and under-treating, particularly in the workup of cancer after failed screenings.  He discusses the development of their innovative prostate cancer diagnostic test.

In Episode 044 of Life Sciences 360, Harsh and Arnon also emphasize the importance of asking the right questions in scientific research and the need for simple and actionable diagnostic tools in healthcare. They advise individuals to stay curious and interested in order to be productive and successful.

-----
Links:

*Arnon LinkedIn
*Cleveland Diagnostics
*Harsh Thakkar LinkedIn
*Would you rather watch on YouTube, Click HERE


👍 Like this video if you enjoy deep dives into healthcare innovations.
🔔 Subscribe to our channel Life Sciences 360 for more expert insights into the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors and Leave us a Review.

----- 
Show Notes:

(00:00) Introduction and Background

(06:26) Choosing Cleveland as a Startup Location

(13:13) Balancing Over-Screening and Under-Treating in Cancer Diagnostics

(18:57) Proteins Involved in the Disease Process

(26:41) The Importance of a Solution that Fits the Final Application

(29:05) The Power of Curiosity and Interest in a Career

(31:18) Final Thoughts and Advice

For more, check out the podcast website - www.lifesciencespod.com